title: Oral aprepitant in the therapy of refractory pruritus in erythrodermic cutaneous T-cell lymphoma.
authors.forename: N
authors.initials: N
authors.lastname: Booken
authors.forename: M
authors.initials: M
authors.lastname: Heck
authors.forename: J P
authors.initials: JP
authors.lastname: Nicolay
authors.forename: C D
authors.initials: CD
authors.lastname: Klemke
authors.forename: S
authors.initials: S
authors.lastname: Goerdt
authors.forename: J
authors.initials: J
authors.lastname: Utikal
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000982:Antipruritics / Q000008:administration & dosage*; D000077608:Aprepitant; D005260:Female; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000008:administration & dosage*; D064729:Neurokinin-1 Receptor Antagonists; D011446:Prospective Studies; D011537:Pruritus / Q000188:drug therapy* / Q000209:etiology; D011788:Quality of Life; D011795:Surveys and Questionnaires
chemical_list: D000982:Antipruritics; D009025:Morpholines; D064729:Neurokinin-1 Receptor Antagonists; D000077608:Aprepitant